Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Virax Biolabs Group (NASDAQ:VRAX) through any online brokerage.
Other companies in Virax Biolabs Group’s space includes: Akso Health Group (NASDAQ:AHG), McKesson Corp (NYSE:MCK), Henry Schein Inc (NASDAQ:HSIC), Accendra Health Inc (NYSE:ACH) and Cencora Inc (NYSE:COR).
Virax Biolabs Group has a consensus price target of $1.00.
The stock price for Virax Biolabs Group (NASDAQ: VRAX) is $0.2713 last updated January 26, 2026 at 1:40 PM EST.
There are no upcoming dividends for Virax Biolabs Group.
Virax Biolabs Group does not have any upcoming earnings scheduled.
There is no upcoming split for Virax Biolabs Group.
Virax Biolabs Group is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.